Skip to main content

GLP-1 Receptor Agonism

Meaning

GLP-1 Receptor Agonism is a therapeutic principle that involves the use of synthetic compounds, known as agonists, to activate the Glucagon-Like Peptide-1 (GLP-1) receptors found in the pancreas, brain, and gastrointestinal tract. Activating these receptors mimics the action of the naturally occurring incretin hormone GLP-1, leading to a cascade of metabolic benefits, including glucose-dependent insulin secretion, slowed gastric emptying, and a significant reduction in appetite and food intake. This mechanism is clinically vital for managing type 2 diabetes and promoting substantial weight loss.